首页> 外国专利> Concentrated suspensions of drugs and their use to produce suspensions for inhalatory administration

Concentrated suspensions of drugs and their use to produce suspensions for inhalatory administration

机译:浓缩药物混悬剂及其在制备用于吸入给药的混悬剂中的用途

摘要

Concentrated suspension of water insoluble pharmaceutical substances, comprising:a) micronized particles of at least one water insoluble pharmaceutical substance with a particle size distribution in which the d(0.5) fraction is less than 3 µm, the span value is less than 2, and such features are retained upon aging the suspension for 90 days; said pharmaceutical substance being present at a concentration of from 5 to 50 times the concentration of a suspension of the same substance for inhalatory administration;b) an aqueous solution of a pharmaceutically acceptable surfactant as dispersing medium for said micronized particles of pharmaceutical substance;c) a salt dissolved in said aqueous solution, at a concentration that: i) does not cause coagulation of said particles of pharmaceutical substance; and ii) generates upon dilution an inhalatory suspension in which the concentration of salt in the aqueous phase is not higher than 10 g/l. present at a concentration of from 0.1 to 2.0 g/l.
机译:水不溶性药物物质的浓缩悬浮液,包括: a)至少一种水不溶性药物物质的微粉化颗粒,其粒径分布中的d(0.5)分数小于3 µm,跨度值小于2,并且在将悬浮液老化90天后保留了这些特征;所述药物物质的浓度为用于吸入给药的相同物质的悬浮液浓度的5至50倍; b)药学上可接受的表面活性剂水溶液作为用于所述微粉化的分散介质药物颗粒; c)溶解在所述水溶液中的盐,其浓度为:i)不会引起所述药物颗粒的凝结; ii)稀释后产生吸入悬浮液,其中水相中盐的浓度不高于10g / l。浓度为0.1至2.0 g / l。

著录项

  • 公开/公告号EP1683514A1

    专利类型

  • 公开/公告日2006-07-26

    原文格式PDF

  • 申请/专利权人 ERATECH S.R.L.;

    申请/专利号EP20050075156

  • 发明设计人 ARTUSI MARIELLA;CAPONETTI GIOVANNI;

    申请日2005-01-20

  • 分类号A61K9/00;A61K9/14;A61K31/573;

  • 国家 EP

  • 入库时间 2022-08-21 21:27:23

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号